p16 involvement in primary bladder tumors: analysis of deletions and mutations.

Author(s):  
E Baud ◽  
P Catilina ◽  
Y J Bignon
1998 ◽  
Vol 159 (5) ◽  
pp. 1770-1770
Author(s):  
L. Lacombe ◽  
I. Orlow ◽  
D. Silver ◽  
W.L. Gerald ◽  
W.R. Fair ◽  
...  

2017 ◽  
Vol 26 (2) ◽  
pp. 120-125 ◽  
Author(s):  
Alexander Feldman ◽  
Samuel Borak ◽  
Soroush Rais-Bahrami ◽  
Jennifer Gordetsky

Although rare, secondary tumors of the bladder can present a diagnostic dilemma to pathologists considering a differential diagnosis of primary bladder cancer. We investigated the clinicopathologic and imaging characteristics of metastatic tumors to the bladder. We retrospectively reviewed the surgical pathology databases from 2 sites from 2013 to 2016, identifying 66 cases of secondary bladder tumors. Clinical, pathologic, and imaging findings were reviewed. Mean age at diagnosis was 63 years (range = 25-87). Females had a significantly higher proportion (44/66, 66.7%) of secondary bladder tumors compared with males (22/66, 33.3%; P = .007). In total, 56/66 (84.8%) patients had a clinical history of an in situ or invasive malignancy in another organ, and 54/66 (81.8%) patients had imaging supporting a metastatic tumor. Only 2/66 (3.0%) patients had a prior history of urothelial carcinoma. In total, 4/66 (6.1%) cases (all females) were originally misdiagnosed as primary bladder malignancies and were corrected after clinicoradiologic correlation. Overall, colorectal origin was most common (15/66, 22.7%), followed by cervical and ovarian primaries (10/66, 15.2% each). Cervical and ovarian origins predominated in the female cohort (10/44, 22.7% each), followed by endometrial (8/44, 18.2%). Colorectal and prostate primaries were the most common among males (10/22, 45.5%, and 7/22, 31.8%, respectively). Secondary bladder tumors can mimic urothelial carcinomas. In our cohort, gynecological, colorectal, and prostatic origins were most common. Clinical history, imaging, and immunohistochemical studies can be useful in avoiding this diagnostic pitfall.


2016 ◽  
Vol 3 (1) ◽  
pp. 55-61
Author(s):  
Matthew R. Danzig ◽  
Ari R. Berg ◽  
Rashed A. Ghandour ◽  
Danny Lascano ◽  
Michael J. Whalen ◽  
...  

1964 ◽  
Vol 91 (5) ◽  
pp. 530-532 ◽  
Author(s):  
Robert J. Marsh ◽  
Frank E. Ceccarelli

1995 ◽  
Vol 14 (3) ◽  
pp. 147-151 ◽  
Author(s):  
Joan P. Packenham ◽  
Jack A. Taylor ◽  
Colleen H. Anna ◽  
Catherine M. White ◽  
Theodora R. Devereux

2012 ◽  
Vol 30 (15_suppl) ◽  
pp. e15015-e15015
Author(s):  
Jue Wang

e15015 Background: Micropapillary bladder carcinoma (MPBC) is a rare variant of urothelial carcinoma. The objective of this study was to examine the epidemiology, natural history, and prognostic factors of MPBC using population-based registry. Methods: The Surveillance, Epidemiology, and End Results (SEER) Program database was used to identify cases of MPBC by tumor site and histology codes. The clinical, demographic characteristics, treatment and survival of MPBC were examined. Results: A total of 98 cases of histology confirmed MPBC were identified between 2001 and 2007, this accounted for approximately 0.01% of all primary bladder tumors during the study period. Median age of the patients was 72 years (range 26-95). Of all the patients with MPBC, 56.1% had muscle invasive disease; 75.5% of patients had poorly or undifferentiated histology. A total of 30.6% of all patients (2.3% superficial disease; 52.7% of muscle-invasive MPBC) had radical or partial cystectomy. By logistic regression analysis, nonmuscle-invasive MPBC (OR 62.5, 95% CI 7.2-542.3) was associated with lower rate of utilization of cystectomy. The 1-, 3- and 5-year overall survival rate of MPBC were 84.5%, 57.3% and 42.3%. In multivariate analysis, tumor stage (HR 4.7, 95% CI 1.0-21.8) was found to be the only significant predictor for cancer-specific survival. Conclusions: The optimal therapy for MPBC remains undermined. Emphasis on early detection is needed to improve the outcome for patients with this malignancy.


2009 ◽  
Vol 181 (4) ◽  
pp. 636
Author(s):  
Yasuo Kohjimoto ◽  
Nagahide Matsumura ◽  
Yasuyo Shintani ◽  
Takeshi Inagaki ◽  
Isao Hara

2021 ◽  
Vol 32 ◽  
pp. S1369-S1370
Author(s):  
M. Dumitru ◽  
M. Mihăilă ◽  
C.M. Hotnog ◽  
M.E. Panait ◽  
M.M. Vasilescu ◽  
...  

2017 ◽  
Vol 197 (4S) ◽  
Author(s):  
Michael Poch ◽  
Maclean Hall ◽  
Krithika Kodumudi Kodumudi ◽  
Cortlin Croft ◽  
Mayer Fishman ◽  
...  

2020 ◽  
Vol 07 (03) ◽  
pp. 52-56
Author(s):  
Cătălina Paranici ◽  
Sanda Achim ◽  
Valentin Enache

Primary bladder angiosarcoma is a rarely encountered and poorly described malignancy. Only 34 cases have been described in the English literature according to PubMed, accounting for only 2% of the genitourinary soft tissue sarcomas and 0.6% of all bladder tumors. We report a case of a primary angiosarcoma of the urinary bladder in an 82-year-old patient and present the clinical history, histopathological and immunohistochemical features of this tumor, in order to provide better understanding of the diagnosis, possible therapies and clinical outcome.


Sign in / Sign up

Export Citation Format

Share Document